BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9443313)

  • 1. Prospects for a parainfluenza virus vaccine.
    Ewasyshyn M; Cates G; Jackson G; Scollard N; Symington A; Klein M
    Pediatr Pulmonol Suppl; 1997; 16():280-1. PubMed ID: 9443313
    [No Abstract]   [Full Text] [Related]  

  • 2. Parainfluenza virus immunization. IV. Simultaneous immunization with parainfluenza types 1, 2, and 3 aqueous vaccines.
    Fulginiti VA; Amer J; Eller JJ; Joyner JW; Askin P
    Am J Dis Child; 1967 Jul; 114(1):26-8. PubMed ID: 4378106
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroepidemiological study of para-influenza viruses in preschool children in Ghana.
    Isomura S; Biritwum RB; Nerome K
    J Trop Pediatr; 1986 Aug; 32(4):181-2. PubMed ID: 3021968
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the epidemiology of child infections. 3. Parainfluenza viruses (types 1-4) and respiratory syncytial virus infections.
    Leogrande G
    Microbios; 1992; 72(290):55-63. PubMed ID: 1335108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
    Jones B; Zhan X; Mishin V; Slobod KS; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2009 Mar; 27(12):1848-57. PubMed ID: 19200447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serologic epidemiological study of parainfluenza 1, 2, and 3 viruses in beef cattle and calves in Illinois.
    Karim A; Ghoneim NH; Woods GT; Mansfield ME; Brown JR
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):437-40. PubMed ID: 2986256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.
    Durbin AP; Elkins WR; Murphy BR
    Vaccine; 2000 May; 18(22):2462-9. PubMed ID: 10738104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses of dairy cattle to parainfluenza-3 virus in intranasal infectious bovine rhinotracheitis-parainfluenza-3 virus vaccines.
    Burroughs AL; Morrill JL; Bostwick JL; Ridley RK; Fryer HC
    Can J Comp Med; 1982 Jul; 46(3):264-6. PubMed ID: 6290012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of parainfluenza viruses in inspiratory difficulties in children.
    Korppi M; Halonen P; Kleemola M; Launiala K
    Acta Paediatr Scand; 1988 Jan; 77(1):105-11. PubMed ID: 2835881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic tests: Parainfluenza virus 1, 2, 3, 4].
    Iwata S
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():349-51. PubMed ID: 16111271
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity against parainfluenza-3 virus in cattle; immunoglobulins in serum and nasal secretions after subcutaneous and nasal vaccination.
    Morein B
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):63-74. PubMed ID: 4377636
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial protection of calves against parainfluenza-3 virus infection by nasal-secretion interferon induced by infectious bovine rhinotracheitis virus.
    Cummins JM; Rosenquist BD
    Am J Vet Res; 1982 Aug; 43(8):1334-8. PubMed ID: 6179445
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunological response of calves after submucosal application of a live vaccine against parainfluenza-3- and adenovirus. (Brief report).
    Haralambiev H
    Arch Exp Veterinarmed; 1975 Jun; 29(3):397-400. PubMed ID: 172040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local production of inflammatory mediators during childhood parainfluenza virus infection.
    El Feghaly RE; McGann L; Bonville CA; Branigan PJ; Suryadevera M; Rosenberg HF; Domachowske JB
    Pediatr Infect Dis J; 2010 Apr; 29(4):e26-31. PubMed ID: 20182399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens.
    Julkunen I
    J Med Virol; 1984; 14(2):177-87. PubMed ID: 6092530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.
    Marx A; Gary HE; Marston BJ; Erdman DD; Breiman RF; Török TJ; Plouffe JF; File TM; Anderson LJ
    Clin Infect Dis; 1999 Jul; 29(1):134-40. PubMed ID: 10433576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to parainfluenza virus types 1, 2 and 3 in sera and nasal secretions of persons of different age.
    Hrusková J; Fedová D; Syrücek L; Pennigerová S; Brûćková M; Holanová L
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):65-70. PubMed ID: 6262404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of vaccines for parainfluenza virus infections.
    Sato M; Wright PF
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vaccination with a parainfluenza type 3 virus on pneumonia resulting from infection with parainfluenza type 3 virus and Pasteurella haemolytica.
    Wells PW; Sharp JM; Rushton B; Gilmour NJ; Thompson DA
    J Comp Pathol; 1978 Apr; 88(2):253-9. PubMed ID: 207750
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to parainfluenza type 3 virus and Pasteurella haemolytica in sheep.
    Wells PW
    Adv Exp Med Biol; 1981; 137():667-76. PubMed ID: 6277166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.